HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jane L Meyer Selected Research

Anthracyclines

9/2012Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jane L Meyer Research Topics

Disease

2Neoplasms (Cancer)
09/2012 - 11/2007
1Breast Neoplasms (Breast Cancer)
09/2012
1Squamous Intraepithelial Lesions
11/2007
1Uterine Cervical Dysplasia
04/2007

Drug/Important Bio-Agent (IBA)

1A-Form DNA (A-DNA)IBA
09/2012
1Methotrexate (Mexate)FDA LinkGeneric
09/2012
1ParaffinIBA
09/2012
1AnthracyclinesIBA
09/2012
1P 11 (P-11)IBA
09/2012
1Formaldehyde (Formol)FDA Link
09/2012
1Keratins (Keratin)IBA
09/2012
1Proteins (Proteins, Gene)FDA Link
11/2007
1IonsIBA
11/2007
1Peptides (Polypeptides)IBA
11/2007
1Cyclin-Dependent Kinase Inhibitor p16IBA
04/2007

Therapy/Procedure

1Palliative Care (Palliative Therapy)
09/2012
1Therapeutics
09/2012
1Drug Therapy (Chemotherapy)
09/2012